Health Care
Washington, DC—Today, Rep. Eric Swalwell (D-CA), Sen. Kyrsten Sinema (D-AZ), Sen. Tim Scott (R-SC), and Rep. Tom Emmer (R-MN) launched the bicameral, bipartisan Congressional Personalized Medicine Caucus. This new caucus seeks to expand support for, and knowledge of, personalized medicine by enhancing public awareness of the field and advocating for policies in support of its advancement. The caucus will engage Members of Congress, staff, and the public in a constructive dialogue on how to best champion this cutting-edge approach to health care.
WASHINGTON, DC – Today, Rep. Eric Swalwell (CA-15) reintroduced the bipartisan Advancing Access to Precision Medicine Act, which would push forward use of genetic and genomic testing to improve health management and save lives.
"It is time we start looking for 21st century cures with 21st century technology," said Swalwell. "Genetic and genomic testing technology is improving every day, and this bill provides a bipartisan way forward for making these tests more accessible to all Americans."
WASHINGTON, DC – Rep. Eric Swalwell (CA-15), the founder and chairman of Future Forum, and other members of that group on Thursday unveiled a policy paper entitled "Cures in Our Lifetime" – a plan for harnessing technology, funding and innovation to save American lives.
WASHINGTON, DC – Rep. Eric Swalwell (CA-15) on Thursday introduced the bipartisan Advancing Access to Precision Medicine Act, to push forward use of genetic and genomic testing to improve and save lives.
The bill's original cosponsors are Rep. John Shimkus (IL-15), Rep. Scott Peters (CA-52), Rep. Erik Paulsen (MN-03), and Rep. Juan Vargas (CA-51).
Congressman Eric Swalwell hosted a town hall meeting last Saturday at Granada High School in Livermore.
He began the session with a touch of humor, noting that upon the birth of his son, "We got the cutest baby monitor from the Russian Ambassador."
WASHINGTON, DC – Rep. Eric Swalwell (CA-15) this week led 12 other House Members in urging that the upcoming budget encourage the Food and Drug Administration (FDA) to increase its educational outreach efforts for life-sciences companies.
WASHINGTON, DC – Rep. Eric Swalwell (CA-15) on Tuesday led 14 other Members of Congress in urging the Department of Health and Human Services (HHS) and Medicare Payment Advisory Commission (MedPAC) to study how to improve access to genetic testing and attain better patient outcomes through precision medicine – individualized healthcare that is the future of successful treatment.
Pleasanton's Congressman Eric Swalwell recently announced he will join the House Judiciary Committee in addition to continuing to serve on the House Permanent Select Committee on Intelligence.
A deputy district attorney in Alameda County before being elected to the House of Representatives, Swalwell said he was "honored" to be selected for the Judiciary Committee, which oversees matters relating to the administration of justice in federal courts, administrative bodies and law enforcement agencies.
WASHINGTON, DC – Rep. Eric Swalwell (D-CA-15) and Rep. Pete Sessions (R-TX-32) led a bipartisan effort to urge the Food and Drug Administration (FDA) to help improve access to clinical trials for cancer treatments.
“The ability or inability to pay travel costs shouldn’t determine who gets to take part in potentially life-saving cancer clinical trials,” said Swalwell. “There’s no reason why a cancer patient’s hopes should be dashed by an empty wallet.”
Washington, DC – U.S. Representative Eric Swalwell (CA-15) today released the following statement after the Supreme Court ruled 6-3 in King v. Burwell to recognize the full intent of the Affordable Care Act (ACA) and protect crucial health care subsidies for 6.4 million Americans: